STOCK TITAN

Gilead Sciences Publishes 2023 ESG Impact Report

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Gilead Sciences recently published its 2023 Environmental, Social, and Governance (ESG) Impact Report, showcasing its achievements in innovating scientific solutions, advancing health equity, empowering communities, and sustaining the planet. The report highlights Gilead's commitment to creating a healthier world while benefiting people, communities, and the environment.
Gilead Sciences ha recentemente pubblicato il suo Rapporto sull'Impatto Ambientale, Sociale e di Governance (ESG) del 2023, mettendo in evidenza i suoi successi nell’innovazione di soluzioni scientifiche, nel promuovere l'equità sanitaria, nell'empowerment delle comunità e nella sostenibilità ambientale. Il rapporto evidenzia l'impegno di Gilead a creare un mondo più sano, a vantaggio delle persone, delle comunità e dell'ambiente.
Gilead Sciences ha publicado recientemente su Informe de Impacto Ambiental, Social y de Gobernanza (ESG) de 2023, destacando sus logros en la innovación de soluciones científicas, el avance en la equidad en salud, el empoderamiento de las comunidades y la sostenibilidad del planeta. El informe resalta el compromiso de Gilead para crear un mundo más saludable, beneficiando a las personas, las comunidades y el medio ambiente.
Gilead Sciences는 최근 2023 환경, 사회 및 거버넌스(ESG) 영향 보고서를 발표했습니다. 이 보고서는 과학적 솔루션 혁신, 건강 평등 증진, 커뮤니티 지원 및 지속 가능한 지구 유지에 대한 업적을 강조합니다. 보고서는 건강한 세계를 창조하면서 사람들, 커뮤니티 및 환경에 혜택을 제공하는 Gilead의 약속을 강조합니다.
Gilead Sciences a récemment publié son Rapport d'Impact Environnemental, Social et de Gouvernance (ESG) de 2023, mettant en avant ses réussites dans l'innovation de solutions scientifiques, l'avancement de l'équité en santé, l'autonomisation des communautés et la durabilité de la planète. Le rapport souligne l'engagement de Gilead à créer un monde plus sain, bénéficiant aux gens, aux communautés et à l'environnement.
Gilead Sciences hat kürzlich seinen Umwelt-, Sozial- und Unternehmensführung (ESG) Auswirkungsbericht für 2023 veröffentlicht, der seine Erfolge bei der Innovation wissenschaftlicher Lösungen, der Förderung der Gesundheitsgerechtigkeit, der Stärkung von Gemeinschaften und der Erhaltung des Planeten hervorhebt. Der Bericht betont Gileads Verpflichtung, eine gesündere Welt zu schaffen, die Menschen, Gemeinschaften und die Umwelt zugute kommt.
Positive
  • None.
Negative
  • None.

NORTHAMPTON, MA / ACCESSWIRE / April 18, 2024 / Gilead Sciences published its 2023 Environmental, Social and Governance (ESG) Impact Report, which uses the ESG framework to highlight the successes and achievements of the prior year.

In this year's report, you will see examples of Gilead's impact across four pillars:

  • Innovating Scientific Solutions
  • Advancing Health Equity and Access
  • Empowering People and Communities
  • Sustaining Our Shared Planet

Learn how we're advancing our vision to create a healthier world while benefiting our people, the communities we support and our planet.

https://www.gilead.com/-/media/files/pdfs/2023-Environmental-Social-Governance-Impact-Report.pdf

Gilead Sciences

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

View additional multimedia and more ESG storytelling from Gilead Sciences on 3blmedia.com.

Contact Info:
Spokesperson: Gilead Sciences
Website: https://www.3blmedia.com/profiles/gilead-sciences
Email: info@3blmedia.com

SOURCE: Gilead Sciences



View the original press release on accesswire.com

Gilead Sciences published its 2023 Environmental, Social, and Governance (ESG) Impact Report.

The ESG Impact Report highlights Gilead's impact across four pillars: Innovating Scientific Solutions, Advancing Health Equity and Access, Empowering People and Communities, and Sustaining Our Shared Planet.

The full 2023 Environmental, Social, and Governance (ESG) Impact Report can be found on Gilead Sciences' website at the provided link.
Gilead Sciences Inc

NASDAQ:GILD

GILD Rankings

GILD Latest News

GILD Stock Data

81.30B
1.24B
0.09%
88.37%
1.81%
Biological Product (except Diagnostic) Manufacturing
Manufacturing
Link
United States of America
FOSTER CITY

About GILD

Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.